by Neoteryx, on September 23,2020
LOS ANGELES and Cambridge, UK — September 2020 — The first commercially available SARS-CoV-2 antibody test in the UK compatible with Neoteryx’s Mitra® Microsampling device for at-home blood collection has …
Read Storyby Neoteryx, on August 14,2020
LOS ANGELES—Medical device company Neoteryx has a reputation for providing extraordinary customer service and support to its scientific and healthcare customers in research, clinical trials, laboratory services, and payer/provider networks. Many …
Read Storyby Neoteryx, on July 18,2020
According to a July 15, 2020 announcement posted on NewsWise, Vysnova Partners Inc., Wake Forest Baptist Health, and several other health organizations have received a $54-million contract from the US …
Read Storyby Neoteryx, on July 16,2020
An article by Jen A. Miller in AACC’s July 2020 online issue of Clinical Laboratory News reports that the COVID-19 pandemic has sparked wider use of telehealth, and a push …
Read Storyby Neoteryx, on June 22,2020
Los Angeles, USA & Canberra, AUSTRALIA — The Mitra® microsampling device from US company Neoteryx has been registered as a Class I in vitro diagnostic (IVD) medical device with the …
Read StoryIf you don’t find the information & assets you need via the buttons below, please contact us here: press@neoteryx.com
